ETFIQData as of Nov 18, 2026. · etfiq.com/funds/buyo

BUYO Fact Sheet: KraneShares Man Buyout Beta Index ETF

Share
$32.45
close, Nov 18, 2026

Over the year to Nov 18, 2026, BUYO returned +24.2% in total and charged 0.89% a year.

1-year total return
+24.2%
IWV +12.0% to Nov 18, 2026
Expense ratio
0.89%
a year
Net assets
$16m
on Nov 18, 2026
Net flow, last 4 trading days
$0
daily basis to Nov 16, 2026

Growth of $10,000, 1 year

BUYO $12,424 +24.2% · IWV $11,199 +12.0% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+0.3%
3 months−4.0%
Year to date+16.7%
1 year+24.2%
Since launch+29.6%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
NEWS CORP - CLASS A1.54%
ENCOMPASS HEALTH CORP1.40%
AFFILIATED MANAGERS GROUP1.20%
MORNINGSTAR INC1.10%
FRONTDOOR INC1.09%
LIFESTANCE HEALTH GROUP INC1.09%
XERIS BIOPHARMA HOLDINGS INC1.06%
TELADOC HEALTH INC1.03%
ASANA INC - CL A1.00%
MATERION CORP0.98%

BUYO top ten by weight, 11.5% of the fund, of its 324 equity positions, from the holdings published by its issuer for Nov 17, 2026.

Facts

Equity fund · Tracks the Man Buyout Beta Index · First traded Oct 8, 2024 · Benchmark Russell 3000 Index, measured by IWV, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, BUYO Fact Sheet: KraneShares Man Buyout Beta Index ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/buyo/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/buyo.